2024 ´ëÇÑ»êºÎÀΰú³»ºÐºñÇÐȸ Á¦33Â÷ Çмú´ëȸ ¹× ¿¬¼ö°Á : 2024-07-07
±³À°ÀÏÀÚ : 2024-07-07
±³À°Àå¼Ò : °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»ç Ȧ
±³À°ÁÖÁ¦ : 2024 ´ëÇÑ»êºÎÀΰú³»ºÐºñÇÐȸ Á¦33Â÷ Çмú´ëȸ ¹× ¿¬¼ö°ÁÂ
ÁÖÃÖ±â°ü : ´ëÇÑ»êºÎÀΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ»êºÎÀΰú³»ºÐºñÇÐȸ
´ã´çÀÚ : ·ùÇöÁØ
¿¬¶ôó : 02-920-5310
À̸ÞÀÏ : kosge2007@empas.com
±³À°Á¾·ù : »êºÎÀΰú
Âü¼®¿¹»óÀÎ : 220¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 90,000¿ø
ºñ°í "»çÀüµî·Ï
- ȸ¿ø : 50,000
- ºñȸ¿ø : 80,000¿ø
- Àü°øÀÇ, ÀüÀÓÀÇ, °£È£»ç : 40,000¿ø
ÇöÀåµî·Ï
- ȸ¿ø : 60,000
- ºñȸ¿ø : 90,000¿ø
- Àü°øÀÇ, ÀüÀÓÀÇ, °£È£»ç : 50,000¿ø"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 08:20~08:50 µî·Ï ±èŹ(°í·ÁÀÇ´ë)
±âŸ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 08:50~08:55 °³È¸»ç ±èŹ(°í·ÁÀÇ´ë)
±âŸ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 08:55~09:00 ÇÁ·Î±×·¥ ¼Ò°³ Á¶½ÃÇö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 09:00~09:20 Application of aI in gynecologic endocrinology ±èÁÖÈñ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 09:20~09:40 Organ-on-a-chip / organoid model in gynecology ¼ºÇÐÁØ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 09:40~10:00 Endobolome, methylation and estrogen metabolism ¾ÈâÈÆ(´ëÇÑ»êºÎÀΰúÀÇ»çȸ ÇмúÀÌ»ç)
Åä·Ð 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 10:00~10:10 Discussion ()
ÈÞ½Ä 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 10:10~10:30 Coffee break ()
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 10:30~10:50 Role of inositol in the management of PCOS: current evidence ±è¶õÈñ(µ¿±¹ÀÇ´ë)
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 10:50~11:10 Medical ( oral pill vs progesterone ) management in PCOS ±èÁøÁÖ(¼¿ïÀÇ´ë)
Åä·Ð 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 11:10~11:20 Discussion ()
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 11:20~11:40 Pros and cons of precocious puberty management äÇö¿í(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 11:40~12:00 Adolescent endometriosis diagnosis and treatment approaches À̵¿À±(¼º±Õ°üÀÇ´ë)
Åä·Ð 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 12:00~12:10 Discussion ()
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 12:10~12:30 Laparo-endoscopic surgery with energy devices for benign gynecologic diseases ·ù±âÁø(°í·ÁÀÇ´ë)
½Ä»ç 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 12:30~13:10 Á¡½É½Ä»ç ()
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 13:10~13:20 (±¸¿¬ ¹ßÇ¥) Establishment of experimental protocols for microplastic exposures in human endometrial cells and possible association in the pathogenesis of endometriosis ¹ÚÇý¹Î(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 13:20~13:30 (±¸¿¬ ¹ßÇ¥)Molecular profiles and properties of human endometrial stem cells in the context of infertility and peceptivity ±èÀ¯Áø(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 13:30~13:40 (±¸¿¬ ¹ßÇ¥)Proteomic analysis of menstrual blood as dried blood spots for discovery of proteins specific to endometriosis Á¤Çý°æ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 13:40~13:50 (±¸¿¬ ¹ßÇ¥)Handgrip Strength and Diabetes Risk in Postmenopausal Women: Insights from the Korean National Health and Nutrition Examination Survey 2014-2019 Á¤¿¬¼ö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 13:50~14:00 (±¸¿¬ ¹ßÇ¥)Prevalence, incidence, and treatment trends of adenomyosis in south korean women for 15 years: a national population-based study ¹ÚÁ¤Çö(°¡Å縯ÀÇ´ë)
Åä·Ð 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 14:00~14:10 Discussion ()
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 14:10~14:30 Korean society of endometriosis clinical guidelines 2024 Àü¼º¿í(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 14:30~14:50 Medical vs surgical, what is the best treatment for endometrioma ? ÀÌ°æ¿í(°í·ÁÀÇ´ë)
Åä·Ð 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 14:50~15:00 Discussion ()
ÈÞ½Ä 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 15:00~15:20 Coffee break ()
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 15:20~15:40 Recent advances in pharmacotherapy for obesity management ÇѺ´´ö(°í·ÁÀÇ´ë)
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 15:40~16:00 Hyperprolactinemia: clinical updates, diagnostic challenges, and treatment Àü½ÂÁÖ(°¡ÃµÀÇ´ë)
Åä·Ð 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 16:00~16:10 Discussion ()
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 16:10~16:30 POI new data and updated guidelines ±èÀ¯Áø(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 16:30~16:50 ÃÖ±Ù ¹Ù²ï °ñ´Ù°øÁõ º¸Çè ±Þ¿© ±âÁØ(T score±âÁØ) ¼Ò°³ Á¤À±Áö(°¡Å縯ÀÇ´ë)
Åä·Ð 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 16:50~17:00 Discussion ()
±âŸ 07¿ù 07ÀÏ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À¯±¤»çȦ 17:00~17:10 ÃÑȸ ±èŹ(°í·ÁÀÇ´ë)